This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: The University of Texas System. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Ramakrishna Edupuganti: Innovator in Cancer Research
Introduction
Ramakrishna Edupuganti is a notable inventor based in Austin, TX (US). He has made significant contributions to the field of cancer research, particularly through his innovative work on indolinone derivatives.
Latest Patents
Ramakrishna holds 1 patent for his invention titled "Indolinone derivatives as inhibitors of maternal embryonic leucine zipper kinase." This patent focuses on indolinone compounds, compositions, and methods aimed at inhibiting maternal embryonic leucine zipper kinase (MELK). The invention also addresses the treatment or prevention of cancers, including triple-negative breast cancer.
Career Highlights
He is affiliated with the University of Texas System, where he continues to advance his research and contribute to the scientific community. His work is pivotal in exploring new therapeutic avenues for cancer treatment.
Collaborations
Ramakrishna has collaborated with esteemed colleagues such as Kevin N Dalby and Juliana Taliaferro, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Ramakrishna Edupuganti's innovative work in cancer research exemplifies the importance of scientific inquiry and collaboration in developing new treatment options. His contributions are vital in the ongoing fight against cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile